Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Submission Of Outcomes Of Board Meeting And Un-Audited Financial Results For The Quarter Ended 31.12.2021 And Year To Date From 01.04.2021 To 31.12. 2021

 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) of the Company for the Quarter ended 31.12.2021 and year to date from 01.04.2021 to 31.12.2021 as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal.
12-02-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the Newspaper Advertisements published for the Notice of Board Meeting to be held on 12th Feburary, 2022, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2021, in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 03rd February, 2022.
04-02-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window

 In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, the 12th February, 2022 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st January, 2022 till 48 hours of declaration of results i.e. 14th February, 2022 (both days inclusive).
02-02-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Holding Of Board Meeting On 12Th February, 2022 To Consider Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2021

 Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2022 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2021. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st January, 2022 till 48 hours of declaration of results i.e. 14th February, 2022 (both days inclusive).
02-02-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Submission Of Signed Minutes Of Annual General Meeting Held On 31.12.2021

 Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2021.
21-01-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Submission Of Signed Minutes Of Annual General Meeting Held On 31.12.2021

 Pursuant to applicable Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the signed copy of Minutes of Annual General Meeting of the Company held on 31st December, 2021.
21-01-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Shareholding for the Period Ended December 31, 2021

 Genomic Valley Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
12-01-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Hanuman PrasadDesignation :- Company Secretary and Compliance Officer
11-01-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith the certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 31st December, 2021.
11-01-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Genomic Valley Biotech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-01-2022
Next Page
Close

Let's Open Free Demat Account